| ||||||||||||||||||||||||||||||||||||||||||||||||||||
15 October 1997 | Volume 127 Issue 5 Part 1 | Pages 618-620
Background: Liver transplantation holds promise as a treatment for familial amyloid polyneuropathy.
Objective: To determine whether peripheral nerves regenerate in patients with familial amyloid polyneuropathy after liver transplantation.
Design: Case report.
Setting: University hospital in Matsumoto, Japan.
Patient: A 34-year-old woman with familial amyloid polyneuropathy who had liver transplantation and showed marked clinical improvement 3 years after surgery.
Measurements: Histopathologic examination and morphometric analysis of biopsy specimens taken from sural nerves.
Results: Diffuse fiber loss and amyloid deposits were seen in a biopsy specimen of the left sural nerve obtained before liver transplantation (total number of myelinated fibers, 1326/mm2 of the endoneurial area). In the biopsy specimen of the right sural nerve, which was obtained 3 years after transplantation, amyloid deposits remained but the number of myelinated fibers was markedly increased (total number of myelinated fibers, 4740/mm2).
Conclusion: Peripheral nerves regenerated in a patient with familial amyloid polyneuropathy after liver transplantation.
In this report, we show a clear histopathologic finding that peripheral nerves regenerated in a patient with familial amyloid polyneuropathy after liver transplantation. BRIEF COMMUNICATION
Peripheral Nerves Regenerated in Familial Amyloid Polyneuropathy after Liver Transplantation
Familial amyloid polyneuropathy is a form of hereditary generalized amyloidosis that is characterized by progressive polyneuropathy and failure of the autonomic nervous system [1]. In patients with this disease, amyloid fibril proteins are single amino acid-substituted variants of transthyretin [2]; the liver produces most of the amyloid fibril proteins present in serum [3]. Liver transplantation has recently been used to treat patients with familial amyloid polyneuropathy [4-7], but little objective evidence supports the use of this treatment.
Case Report
![]()
Top
Case Report
Methods
Results
Discussion
Author & Article Info
References
A 31-year-old woman with a 3-year history of type I familial amyloid polyneuropathy had undergone living-related partial liver transplantation, as reported elsewhere [8, 9]. Liver transplantation from a cadaveric donor is not performed in Japan because the Japanese do not believe that brain death constitutes death. The patient had a mutant transthyretin gene with a valine to methionine substitution at position 30 (30Met transthyretin). The donor was the patient's healthy 33-year-old sister. After surgery, the patient's autonomic neurologic dysfunction (bowel and bladder dysfunction and orthostatic hypotension) and neuropathic symptoms in the lower limbs gradually disappeared. In addition, 30Met transthyretin in serum almost disappeared [8]. One year after transplantation, the patient returned to her previous activities. Three years after transplantation, she has no residual symptoms ascribed to familial amyloid polyneuropathy. A series of motor and sensory nerve conduction studies on the right tibial nerve showed slight improvement after transplantation: Motor nerve conduction was 43.0 m/s before and 41.0 m/s 3 years after transplantation; sensory nerve conduction was 38.0 m/s before and 48.0 m/s 3 years after transplantation (normal values: motor nerve conduction,
40 m/s; sensory nerve conduction,
35 m/s).
Methods
![]()
Top
Case Report
Methods
Results
Discussion
Author & Article Info
References
Biopsy was done on the left sural nerve before liver transplantation and on the right sural nerve 3 years after transplantation. Formalin-fixed and paraffin-embedded sections were stained with alkaline Congo red, and the characteristic apple-green birefringence of amyloid was identified under a polarizing microscope. So that we could study myelinated fiber lesions, the specimens were fixed in 3% glutaraldehyde in 0.1 mole of cacodylate buffer at a pH of 7.4, postfixed in 1% osmium tetroxide in the same buffer, and embedded in epoxy resin. Transverse sections of 1-µm thickness were cut, stained with 1% toluidine blue, and examined by light microscopy. The diameter of the myelinated fiber and the density of the fiber per square millimeter of the endoneurial area were estimated from photographs enlarged to a final magnification of x1000. From these results, histograms of diameter frequency were constructed.
Results
![]()
Top
Case Report
Methods
Results
Discussion
Author & Article Info
References
Before transplantation, amyloid deposits were seen in the epineurium, perineurium, and endoneurium of the left sural nerve; a nodular pattern of amyloid deposits in the endoneurium predominated. A generalized, severe reduction in the density of nerve fibers was seen in each fascicle (Figure 1, left; Figure 2). After transplantation, a similar pattern of amyloid deposits was seen in the right sural nerve but the size of these deposits seemed stable (Figure 1, middle inset). The density of myelinated fibers was much higher after transplantation than before transplantation. In particular, the number of small myelinated fibers was much higher after transplantation than before transplantation (Figure 1, middle and right; Figure 2).
|
|
Discussion
|
|---|
|
|
|---|
The clinical evidence has led to a consensus that liver transplantation is a promising treatment for familial amyloid polyneuropathy. The need for early transplantation in less symptomatic patients is now emphasized. However, little objective evidence has documented the regression of amyloid deposits or the recovery of peripheral nerves. Studies of scintigraphy done by using radiolabeled serum amyloid P component have shown a significant decrease in whole-body uptake of this tracer after liver transplantation; this finding indicates that amyloid-laden lesions regressed [6]. Results on autonomic function tests improved in a patient with familial amyloid polyneuropathy who survived 8 months after liver transplantation [15].
Type I familial amyloid polyneuropathy with variant 30Met transthyretin usually features distal to proximal symmetrical involvement of peripheral nerves that starts in the legs [1]. A primary neuropathic process in this disorder is axonal degeneration caused by local amyloid deposits [16]. It is well known that the pathologic feature of sural nerve biopsy specimens is selective loss of unmyelinated and small myelinated fibers in the early stage of disease [17]. In our patient, clinical improvement was accompanied by a change in the population of myelinated fibers in the left and right sural nerves. The diffuse pattern of nerve fiber loss in the biopsy specimen of the left sural nerve obtained before liver transplantation coincided with the findings of sural nerves seen in patients with advanced type I familial amyloid polyneuropathy. The biopsy specimen obtained from the right sural nerve 3 years after transplantation revealed a substantial increase in the number of myelinated fibers and many small myelinated fibers. Because patients in whom type I familial amyloid polyneuropathy has a progressively deteriorating course seldom have well-preserved small myelinated fibers in the biopsy specimens obtained from the sural nerves [16], our findings indicate that myelinated fibers regenerate in the peripheral nerves after liver transplantation. Moreover, the reduction of amyloid mass seems to occur in the proximal portions of the long extremity nerves. This report provides valuable histopathologic evidence of the usefulness of liver transplantation as therapy for familial amyloid polyneuropathy.
Dr. Yanagisawa: National Institute for Longevity Sciences and National Chuubu Hospital, Obu 474, Aichi, Japan.
Dr. Matsunami: Department of Surgery, Matsunami General Hospital, Hashiba 501-61, Gifu, Japan.
Drs. Hashikura, Ikegami, and Kawasaki: Department of Surgery, Shinshu University School of Medicine, Matsumoto 390, Japan.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, et al. Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain. 1987; 110:315-37.
2. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest. 1996; 3:44-56.
3. Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman D. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem. 1985; 260:11793-8.
4. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, et al. Biochemical effects of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet. 1991; 40:242-6.
5. Steen L, Holmgren G, Suhr O, Wikstrom L, Groth CL, Ericzon BG. World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid: Int J Exp Clin Invest. 1994; 1:138-42.
6. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993; 341:1113-6.
7. Skinner M, Lewis WD, Jones LA, Kasirsky J, Kane K, Ju ST, et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med. 1994; 12:133-4.
8. Matsunami H, Makuuchi M, Kawasaki S, Hashikura Y, Ikegami T, Nakazawa Y, et al. A case of familial amyloid polyneuropathy treated with partial liver transplantation using a graft from a living related donor. Transplantation. 1995; 60:301-3.
9. Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Ikegami T, et al. Partial liver transplantation from living donors in familial amyloid polyneuropathy. Amyloid: Int J Exp Clin Invest. 1997; 4:18-8.
10. Ericzon BG. Liver transplantation for familial amyloid polyneuropathy-report from the world registry. Neuromusc Disord. 1996; 6(Suppl 1):65.
11. Parrilla P, Ramirez P, Bueno FS, Robles R, Acosta F, Miras M, et al. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Surg. 1995; 82:825-8.
12. Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation. 1995; 60:933-8.
13. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology. 1996; 46:944-51.
14. Jonsen E, Suhr O, Athlin E, Wikstrom L. Quality of life after liver transplantation in patients with familial amyloid polyneuropathy. Amyloid: Int J Exp Clin Invest. 1996; 3:124-9.
15. Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I [Letter]. Lancet. 1995; 345:195-6.
16. Hanyu N, Ikeda S, Nakadai A, Yanagisawa N, Powell HC. Peripheral nerve pathological findings in familial amyloid polyneuropathy: a correlative study of proximal sciatic nerve and sural nerve lesions. Ann Neurol. 1989; 25:340-50.
17. Dyck PJ, Lambert EH. Dissociated sensation in amyloidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol. 1969; 20:490-507.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||